Santen Pharmaceutical Co(DE:SZD)
€11.30+0.20 (+1.80%)
DE:SZD
Santen Pharmaceutical Co earnings date
€11.30
At close:+0.20 (+1.80%)
Santen Pharmaceutical Co (SZD) Q2 2026 Earnings Report
0 Followers
DE:SZD Q2 2026 EPS Results
- Actual EPS
- EUR 0.14
- Consensus EPS
- EUR 0.18
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- EUR 0.14
DE:SZD Q2 2026 Revenue Results
- Actual Revenue
- EUR 418.83M
- Expected Revenue
- EUR 410.17M
- Beat/Miss
- Beat by +EUR 8.66M
- YoY Revenue Growth
- +7.51%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/05/2026
- Time
- TBA
- Conference Call
- Thursday, November 5, 2026
DE:SZD Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:SZD Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:SZD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | 0.21- | 0.14 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | 0.180.14 | 0.14 | 5.03% (+0.01) | |
| Aug 06, 2026 | 2026 (Q1) | 0.120.13 | 0.1 | 29.21% (+0.03) | |
| May 12, 2026 | 2025 (Q4) | 0.170.27 | 0.15 | 85.80% (+0.12) | |
| Feb 05, 2026 | 2025 (Q3) | 0.170.14 | 0.14 | -3.67% (-0.01) | |
| Nov 06, 2025 | 2025 (Q2) | 0.120.14 | 0.13 | 4.94% (+0.01) | |
| Aug 07, 2025 | 2025 (Q1) | 0.130.10 | 0.17 | -41.47% (-0.07) | |
| May 13, 2025 | 2024 (Q4) | 0.100.15 | 0.09 | 57.30% (+0.05) | |
| Feb 06, 2025 | 2024 (Q3) | 0.150.14 | 0.11 | 25.40% (+0.03) | |
| Nov 07, 2024 | 2024 (Q2) | 0.120.13 | 0.14 | -3.48% (-0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
